Effect of intermittent oral administration of ponazuril on experimental Sarcocystis neurona infection of horses
Authors:
- Susan T. TanhauserSTSusan T. Tanhauser
- Karen D. GillisKGKaren D. Gillis
- Ian G. MayhewIMIan G. Mayhew
- Tom J. KennedyTKTom J. Kennedy
- 1 March 2008
- journal article
- research article
- Published by American Veterinary Medical Association (AVMA) in American Journal of Veterinary Research
- Vol. 69 (3) , 396-402
Abstract
Objective—To evaluate the effect of intermittent oral administration of ponazuril on immunoconversion against Sarcocystis neurona in horses inoculated intragastrically with S neurona sporocysts. Animals—20 healthy horses that were seronegative for S neurona–specific IgG. Procedures—5 control horses were neither inoculated with sporocysts nor treated. Other horses (5 horses/group) each received 612,500 S neurona sporocysts via nasogastric tube (day 0) and were not treated or were administered ponazuril (20 mg/kg, PO) every 7 days (beginning on day 5) or every 14 days (beginning on day 12) for 12 weeks. Blood and CSF samples were collected on day – 1 and then every 14 days after challenge for western blot assessment of immunoconversion. Clinical signs of equine protozoal myeloencephalitis (EPM) were monitored, and tissues were examined histologically after euthanasia. Results—Sera from all challenged horses yielded positive western blot results within 56 days. Immunoconversion in CSF was detected in only 2 of 5 horses that were treated weekly; all other challenged horses immunoconverted within 84 days. Weekly administration of ponazuril significantly reduced the antibody response against the S neurona 17-kd antigen in CSF. Neurologic signs consistent with EPM did not develop in any group; likewise, histologic examination of CNS tissue did not reveal protozoa or consistent degenerative or inflammatory changes. Conclusions and Clinical Relevance—Administration of ponazuril every 7 days, but not every 14 days, significantly decreased intrathecal anti–S neurona antibody responses in horses inoculated with S neurona sporocysts. Protocols involving intermittent administration of ponazuril may have application in prevention of EPM.Keywords
This publication has 37 references indexed in Scilit:
- Antibody index and specific antibody quotient in horses after intragastric administration of Sarcocystis neurona sporocystsAmerican Journal of Veterinary Research, 2008
- Evidence to support horses as natural intermediate hosts for Sarcocystis neuronaVeterinary Parasitology, 2005
- Parasitemia in an immunocompetent horse experimentally challenged with Sarcocystis neurona sporocystsVeterinary Parasitology, 2005
- AN EQUINE PROTOZOAL MYELOENCEPHALITIS CHALLENGE MODEL TESTING A SECOND TRANSPORT AFTER INOCULATION WITH SARCOCYSTIS NEURONA SPOROCYSTSJournal of Parasitology, 2004
- Intrathecal Immune Response Pattern for Improved Diagnosis of Central Nervous System Involvement in TrypanosomiasisThe Journal of Infectious Diseases, 2003
- EXPERIMENTAL INDUCTION OF EQUINE PROTOZOAN MYELOENCEPHALITIS (EPM) IN THE HORSE: EFFECT OF SARCOCYSTIS NEURONA SPOROCYST INOCULATION DOSE ON THE DEVELOPMENT OF CLINICAL NEUROLOGIC DISEASEJournal of Parasitology, 2002
- Antigen-Specific Antibodies in Cerebrospinal Fluid after Intramuscular Injection of Ovalbumin in HorsesJournal of Veterinary Internal Medicine, 2002
- Antigen-Specific Antibodies in Cerebrospinal Fluid after Intramuscular Injection of Ovalbumin in HorsesJournal of Veterinary Internal Medicine, 2002
- The striped skunk (Mephitis mephitis) is an intermediate host for Sarcocystis neuronaInternational Journal for Parasitology, 2001
- Isolation in immunodeficient mice of Sarcocystis neurona from opossum (Didelphis virginiana) faeces, and its differentiation from Sarcocystis falcatulaInternational Journal for Parasitology, 1998